Volume | 2,874 |
|
|||||
Noticias | (1) | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Roche Holding Ag | 0QQ6 | London | Acción Ordinaria |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
229.20 | 229.20 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
35 | 2,874 | - | 229.20 - 229.20 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
11:57:37 | O | 9 | CHF 237.0904 | CHF |
Información Financiera Roche Holding Ag 0QQ6
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
0 | 0.00 | - | 58.72B | 11.5B | - | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Roche Holding Ag 0QQ6
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
19/4/2024 | 00:00 | UK Regulatory | FDA approves Roche’s Alecensa as the first adjuvant.. |
17/4/2024 | 01:00 | UK Regulatory | Roche’s subcutaneous OCREVUS one-year data demonstrates.. |
15/4/2024 | 00:00 | UK Regulatory | [Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi.. |
11/4/2024 | 00:00 | UK Regulatory | Roche granted FDA Breakthrough Device Designation for blood.. |
26/3/2024 | 11:45 | UK Regulatory | Roche receives FDA approval for the first molecular test to.. |
12/3/2024 | 07:30 | UK Regulatory | Roche Annual General Meeting 2024 |
12/3/2024 | 07:30 | UK Regulatory | Roche Generalversammlung 2024 |
12/3/2024 | 07:30 | UK Regulatory | Assemblée générale 2024 de Roche |
05/3/2024 | 06:30 | UK Regulatory | Roche and Alnylam report positive topline results from the.. |
25/2/2024 | 13:00 | UK Regulatory | New England Journal of Medicine publishes Phase III data.. |
16/2/2024 | 10:24 | UK Regulatory | FDA approves Xolair as first and only medicine for children.. |
01/2/2024 | 00:03 | UK Regulatory | New long-term data for Roche’s Vabysmo show sustained.. |
Histórico de Datos 0QQ6
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 229.20 | 229.20 | 229.20 | 229.20 | 1,177 | 0.00 | 0.00% |
1 Month | 229.20 | 229.20 | 229.20 | 229.20 | 3,345 | 0.00 | 0.00% |
3 Months | 229.20 | 229.20 | 229.20 | 229.20 | 7,939 | 0.00 | 0.00% |
6 Months | 229.20 | 229.20 | 229.20 | 229.20 | 6,381 | 0.00 | 0.00% |
1 Year | 229.20 | 229.20 | 229.20 | 229.20 | 7,304 | 0.00 | 0.00% |
3 Years | 229.20 | 229.20 | 229.20 | 229.20 | 6,142 | 0.00 | 0.00% |
5 Years | 229.20 | 229.20 | 229.20 | 229.20 | 4,529 | 0.00 | 0.00% |